课题基金 / 基金详情

项目摘要

项目成果

DENNIS E HALLAHAN的其他基金

相似基金

相关文献

中文摘要
翻译

英文摘要
 DESCRIPTION (provided by applicant): Washington University in St. Louis has a rich tradition of radiation research and is a world leader in the field of radiation oncology for clinical care, a well as physics and biological research. Over the past twenty years, much emphasis has been placed on the development of instrumentation for the non-invasive imaging of biological processes in small animals, thereby providing investigators with a better understanding of the biology and the potential of therapeutic interventions in preclinical models. In this regard, Washington University is a recognized leader, with outstanding programs and instrumentation for preclinical magnetic resonance, nuclear, and optical imaging. Preclinical photon irradiators that can deliver radiation to precise anatomical locations in small animals are an important component of these research efforts. We therefore request funds to purchase the Xstrahl small animal radiation research platform (SARRP). Components of the SARRP include: a 225kV x- ray tube, x-ray controller, SARRP interface and PC, robotic specimen stage, safety interlock system, cone beam CT imaging system, and integrated shielding. Ten major users with NIH funding form the initial user base for the SARRP, along with three minor users. The PI has more than 25 years of expertise in clinical radiation oncology and in radiation and cancer biology research, with a primary focus is in drug development for treatment of cancer. He has assembled a strong team to oversee operations and QA of the instrument. In addition, Washington University has made a significant institutional commitment to ensure the successful use of the device after its installation. The irradiator will allow investigators to study basic questions regarding radiation research in an in vivo, pre-clinical model that will eventually lead to new paradigms in the way we treat disease in the clinical setting.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1080/09553002.2023.2194404
发表时间: 2023
期刊: International journal of radiation biology
影响因子: 2.6
作者: []
通讯作者:
Tiptuximab Immunotherapeutic for Cancer
  • 批准号:
    8830123
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2014
  • 负责人:
    DENNIS E HALLAHAN
  • 依托单位:
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS
  • 批准号:
    8628818
  • 项目类别:
  • 资助金额:
    $44.16万
  • 财政年份:
    2013
  • 负责人:
    DENNIS E HALLAHAN
  • 依托单位:
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS
  • 批准号:
    8479896
  • 项目类别:
  • 资助金额:
    $45.53万
  • 财政年份:
    2013
  • 负责人:
    DENNIS E HALLAHAN
  • 依托单位:
THE ROLE OF PROTEIN PHOSPHATASE PP2A IN RADIATION INDUCED STEM CELL APOPTOSIS
  • 批准号:
    8828607
  • 项目类别:
  • 资助金额:
    $45.53万
  • 财政年份:
    2013
  • 负责人:
    DENNIS E HALLAHAN
  • 依托单位:
海外基金